- Genentech’s drug Lucentis can now be administered through a prefilled syringe form.
- Wayne, Pa.-based Teleflex developed the Arrow Midline catheter.
- Indianapolis-based Eli Lilly’s drug Lartruvo is intended to treat patients with advanced soft tissue sarcoma.
- Roche’s bladder cancer drug Tecentriq can now be used as a second-line treatment for patients with metastatic non-small cell lung cancer.
More articles on supply chain:
‘Project Toto’: CVS Health to open large distribution center in Kansas
FDA funds $23M in grants to spur rare disease drug research
J&J sales increase 4% in Q3: 4 things to know
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.